Literature DB >> 32960680

Retromer regulates the lysosomal clearance of MAPT/tau.

Julian M Carosi1,2,3, Leanne K Hein1, Mark van den Hurk4, Robert Adams4,5, Bridget Milky4,5, Sanjna Singh1,6, Cedric Bardy4,5, Donna Denton2, Sharad Kumar2, Timothy J Sargeant1.   

Abstract

The macroautophagy/autophagy-lysosome axis enables the clearance and degradation of cytoplasmic components including protein aggregates, damaged organelles and invading pathogens. Protein aggregation and lysosomal system dysfunction in the brain are common features of several late-onset neurological disorders including Alzheimer disease. Spatial overlap between depletion of the endosomal-sorting complex retromer and MAPT/tau aggregation in the brain have been previously reported. However, whether retromer dysfunction plays a direct role in mediating MAPT aggregation remains unclear. Here, we demonstrate that the autophagy-lysosome axis is the primary mode for the clearance of aggregated species of MAPT using both chemical and genetic approaches in cell models of amyloid MAPT aggregation. We show that depletion of the central retromer component VPS35 causes a block in the resolution of autophagy. We establish that this defect underlies marked accumulation of cytoplasmic MAPT aggregates upon VPS35 depletion, and that VPS35 overexpression has the opposite effect. This work illustrates how retromer complex integrity regulates the autophagy-lysosome axis to suppress MAPT aggregation and spread.

Entities:  

Keywords:  Amyloid; VPS35; autophagy; lysosome; protein aggregation; tauopathy

Mesh:

Substances:

Year:  2020        PMID: 32960680      PMCID: PMC8496733          DOI: 10.1080/15548627.2020.1821545

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  80 in total

1.  Dopaminergic differentiation of human pluripotent cells.

Authors:  Leah F Boyer; Benjamin Campbell; Samantha Larkin; Yanling Mu; Fred H Gage
Journal:  Curr Protoc Stem Cell Biol       Date:  2012-08

Review 2.  Autophagy Receptors and Neurodegenerative Diseases.

Authors:  Zhiqiang Deng; Kerry Purtell; Veronik Lachance; Mitchell S Wold; Shi Chen; Zhenyu Yue
Journal:  Trends Cell Biol       Date:  2017-02-03       Impact factor: 20.808

3.  A novel fluorescent probe reveals starvation controls the commitment of amyloid precursor protein to the lysosome.

Authors:  Leanne K Hein; Pirjo M Apaja; Kathryn Hattersley; Randall H Grose; Jianling Xie; Christopher G Proud; Timothy J Sargeant
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-06-19       Impact factor: 4.739

4.  Processing of human cathepsin D in lysosomes in vitro.

Authors:  V Gieselmann; A Hasilik; K von Figura
Journal:  J Biol Chem       Date:  1985-03-10       Impact factor: 5.157

Review 5.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

6.  VPS35 mutations in Parkinson disease.

Authors:  Carles Vilariño-Güell; Christian Wider; Owen A Ross; Justus C Dachsel; Jennifer M Kachergus; Sarah J Lincoln; Alexandra I Soto-Ortolaza; Stephanie A Cobb; Greggory J Wilhoite; Justin A Bacon; Bahareh Behrouz; Heather L Melrose; Emna Hentati; Andreas Puschmann; Daniel M Evans; Elizabeth Conibear; Wyeth W Wasserman; Jan O Aasly; Pierre R Burkhard; Ruth Djaldetti; Joseph Ghika; Faycal Hentati; Anna Krygowska-Wajs; Tim Lynch; Eldad Melamed; Alex Rajput; Ali H Rajput; Alessandra Solida; Ruey-Meei Wu; Ryan J Uitti; Zbigniew K Wszolek; François Vingerhoets; Matthew J Farrer
Journal:  Am J Hum Genet       Date:  2011-07-15       Impact factor: 11.025

7.  Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease.

Authors:  Matthew R Brier; Brian Gordon; Karl Friedrichsen; John McCarthy; Ari Stern; Jon Christensen; Christopher Owen; Patricia Aldea; Yi Su; Jason Hassenstab; Nigel J Cairns; David M Holtzman; Anne M Fagan; John C Morris; Tammie L S Benzinger; Beau M Ances
Journal:  Sci Transl Med       Date:  2016-05-11       Impact factor: 17.956

8.  Full recovery of the Alzheimer's disease phenotype by gain of function of vacuolar protein sorting 35.

Authors:  Jian-Guo Li; Jin Chiu; Domenico Praticò
Journal:  Mol Psychiatry       Date:  2019-02-07       Impact factor: 13.437

Review 9.  Retromer and the cation-independent mannose 6-phosphate receptor-Time for a trial separation?

Authors:  Matthew N J Seaman
Journal:  Traffic       Date:  2017-12-21       Impact factor: 6.215

10.  Promoting tau secretion and propagation by hyperactive p300/CBP via autophagy-lysosomal pathway in tauopathy.

Authors:  Xu Chen; Yaqiao Li; Chao Wang; Yinyan Tang; Sue-Ann Mok; Richard M Tsai; Julio C Rojas; Anna Karydas; Bruce L Miller; Adam L Boxer; Jason E Gestwicki; Michelle Arkin; Ana Maria Cuervo; Li Gan
Journal:  Mol Neurodegener       Date:  2020-01-06       Impact factor: 14.195

View more
  8 in total

Review 1.  Autophagy in major human diseases.

Authors:  Daniel J Klionsky; Giulia Petroni; Ravi K Amaravadi; Eric H Baehrecke; Andrea Ballabio; Patricia Boya; José Manuel Bravo-San Pedro; Ken Cadwell; Francesco Cecconi; Augustine M K Choi; Mary E Choi; Charleen T Chu; Patrice Codogno; Maria Isabel Colombo; Ana Maria Cuervo; Vojo Deretic; Ivan Dikic; Zvulun Elazar; Eeva-Liisa Eskelinen; Gian Maria Fimia; David A Gewirtz; Douglas R Green; Malene Hansen; Marja Jäättelä; Terje Johansen; Gábor Juhász; Vassiliki Karantza; Claudine Kraft; Guido Kroemer; Nicholas T Ktistakis; Sharad Kumar; Carlos Lopez-Otin; Kay F Macleod; Frank Madeo; Jennifer Martinez; Alicia Meléndez; Noboru Mizushima; Christian Münz; Josef M Penninger; Rushika M Perera; Mauro Piacentini; Fulvio Reggiori; David C Rubinsztein; Kevin M Ryan; Junichi Sadoshima; Laura Santambrogio; Luca Scorrano; Hans-Uwe Simon; Anna Katharina Simon; Anne Simonsen; Alexandra Stolz; Nektarios Tavernarakis; Sharon A Tooze; Tamotsu Yoshimori; Junying Yuan; Zhenyu Yue; Qing Zhong; Lorenzo Galluzzi; Federico Pietrocola
Journal:  EMBO J       Date:  2021-08-30       Impact factor: 14.012

Review 2.  Pharmacological modulation of autophagy for Alzheimer's disease therapy: Opportunities and obstacles.

Authors:  Zhiqiang Deng; Yu Dong; Xiaoting Zhou; Jia-Hong Lu; Zhenyu Yue
Journal:  Acta Pharm Sin B       Date:  2021-12-18       Impact factor: 14.903

3.  Dysregulation of the Retromer Complex in Brain Endothelial Cells Results in Accumulation of Phosphorylated Tau.

Authors:  Alessia Filippone; Tiffany Smith; Domenico Pratico
Journal:  J Inflamm Res       Date:  2021-12-29

Review 4.  Modelling the functional genomics of Parkinson's disease in Caenorhabditis elegans: LRRK2 and beyond.

Authors:  Rachael J Chandler; Susanna Cogo; Patrick A Lewis; Eva Kevei
Journal:  Biosci Rep       Date:  2021-09-30       Impact factor: 3.840

5.  Association of Retromer Deficiency and Tau Pathology in Down Syndrome.

Authors:  Mary Elizabeth Curtis; Tiffany Smith; Daohai Yu; Domenico Praticò
Journal:  Ann Neurol       Date:  2022-02-25       Impact factor: 11.274

6.  Retromer deficiency in Tauopathy models enhances the truncation and toxicity of Tau.

Authors:  Jamshid Asadzadeh; Evelyne Ruchti; Wei Jiao; Greta Limoni; Catherine MacLachlan; Scott A Small; Graham Knott; Ismael Santa-Maria; Brian D McCabe
Journal:  Nat Commun       Date:  2022-08-27       Impact factor: 17.694

7.  The neuronal retromer can regulate both neuronal and microglial phenotypes of Alzheimer's disease.

Authors:  Yasir H Qureshi; Diego E Berman; Samuel E Marsh; Ronald L Klein; Vivek M Patel; Sabrina Simoes; Suvarnambiga Kannan; Gregory A Petsko; Beth Stevens; Scott A Small
Journal:  Cell Rep       Date:  2022-01-18       Impact factor: 9.423

Review 8.  The mTOR-lysosome axis at the centre of ageing.

Authors:  Julian M Carosi; Célia Fourrier; Julien Bensalem; Timothy J Sargeant
Journal:  FEBS Open Bio       Date:  2021-12-18       Impact factor: 2.693

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.